Lupus nephritis: Histology, diagnosis, and treatment

Bulletin of the NYU Hospital for Joint Diseases

Volumn 66, Issue 3, 2008, Pages 188-194

  Tumlin, James A ^a,b  

^a UNIVERSITY OF TENNESSEE AT CHATTANOOGA   (United States)

^b Southeast Aquatic Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; DNA ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MICROSCOPY; PREVALENCE; PROTEIN URINE LEVEL; SURVIVAL RATE; URINE SEDIMENT; WORLD HEALTH ORGANIZATION;

BIOPSY; HUMANS; KIDNEY; LUPUS NEPHRITIS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 53649098285     PISSN: 19369719     EISSN: 19369727     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Roberti I, Dikman S, Spiera H, et al. Comparative value of urinalysis, urine cytology and urine sIL2R in the assessment of renal disease in patients with systemic lupus erythematosus (SLE). Clin Nephrol. 1996 Sep;46(3):176-82.
2. Zimmerman SW, Jenkins PG, Shelf WD, et al. Progression from minimal or focal to diffuse proliferative lupus nephritis. Lab Invest. 1975 May;32(5):665-72.
3. Appel GB, Cohen DJ, Pirani CL, et al. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med. 1987 Nov;83(5):877-85.
4. Najafi CC, Korbet SM, Lewis EJ, et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 2001 Jun;59(6):2156-63.
5. Hill GS, Delahousse M, Nochy D, et al. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages. Kidney Int. 2001 Jan;59(1):304-16.
6. Valeri A, Radhakrishnan J, Estes D, et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study. Clin Nephrol. 1994 Aug;42(2):71-8.
7. Sloan RP, Schwartz MM, Korbet SM, Borok RZ. Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group. J Am Soc Nephrol. 1996 Feb;7(2):299-305.
8. Kolasinski SL, Chung JB, Albert DA. What do we know about lupus membranous nephropathy? An analytic review. Arthritis Rheum. 2002 Aug;47(4):450-5.
9. Eiser AR, Katz SM, Swartz C. Clinically occult diffuse proliferative lupus nephritis: an age-related phenomenon. Arch Intern Med. 1979 Sep;139(9):1022-5.
10. Jacobsen S, Starklint H, Petersen J, et al. Prognostic value of renal biopsy and clinical variables in patients with lupus nephritis and normal serum creatinine. Scand J Rheumatol. 1999;28(5):288-99.
11. Austin HA 3rd, Klippel JH, Balow JE, et al. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986 Mar 6;314(10):614-9.
12. Austin HA 3rd, Boumpas DT, Vaughan EM, Balow JE. High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant. 1995;10(9):1620-8.
13. Dooley MA, Hogan S, Jennette C, Falk R. Cyclophosphamide therapy for lupus nephritis: poorrenal survival in black Americans. Glomerular Disease Collaborative Network. Kidney Int. 1997 Apr;51(4):1188-95.
14. Illei GG, Austin HA, Crane M, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Ann Intern Med. 2001 Aug 21;135(4):248-57.
15. Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med. 2005 Nov 24;353(21):2219-28.
16. Mosca M, Bencivelli W, Neri R, et al. Renal flares in 91 SLE patients with diffuse proliferative glomerulonephritis. Kidney Int. 2002 Apr;61(4):1502-9.
17. Ioannidis JP, Boki KA, Katsorida ME, et al. Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide. Kidney Int. 2000 Jan;57(1):258-64.
18. Moroni G, Pasquali S, Quaglini S, et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis. 1999 Sep;34(3):530-9.